EurekAlert! – Towards the goal of precision therapy in hepatocellular carcinoma

Hepatocellular carcinoma is a highly lethal disease, therefore effective and tolerable treatment is urgently needed.

Advances in understanding the molecular genetics of hepatocellular neoplasia have been made, and developing targeted therapeutics in combination with molecular tumor profiling may help accomplish the goal of precision treatment of patients with hepatocellular carcinoma (HCC).

In a recently published article, Dr. Nelson Yee and Dr. Eric Marks provide an updated review of the genetic abnormalities and mechanisms that drive carcinogenesis of HCC, and discuss the targeted therapeutics clinically investigated in patients with this disease.

The article is published in Current Cancer Drug Targets 2016; volume 16, issue 1, pages 53-70.

Eric I. Marks and Nelson S Yee.

Penn State Hershey Cancer Institute, 500 University Drive, Hershey, Pennsylvania, USA

Read more here:

Author: Bentham Science Publishers

A major STM journal publisher of more than 100 online and print journals and related print/online book series, Bentham Science answers the information needs of scientists in the fields of pharmaceutical, biomedical, medical, engineering, technology, computer and social sciences.

Leave a Reply

Please log in using one of these methods to post your comment: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: